| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| OptimizeRx Corp | Chief Product & Tech Officer | Common Stock | 66,876 | $852,000 | $12.74 | 23 Dec 2025 | Direct |
| OptimizeRx Corp | Chief Product & Tech Officer | Restricted Stock Units | 1,964 | $42,030 | $10.70 | 19 Dec 2025 | Direct |
| OptimizeRx Corp | Chief Product & Tech Officer | Stock Option | 35,156 | 21 Aug 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | 23 Dec 2025 | 1 | -$51,966 | 4 | Chief Product & Tech Officer | 23 Dec 2025, 16:53 |
| OPRX | OptimizeRx Corp | 19 Dec 2025 | 3 | -$7,849 | 4 | Chief Product & Tech Officer | 22 Dec 2025, 10:07 |
| OPRX | OptimizeRx Corp | 03 Oct 2025 | 3 | -$18,431 | 4 | Chief Product & Tech Officer | 07 Oct 2025, 17:52 |
| OPRX | OptimizeRx Corp | 21 Aug 2025 | 2 | $0 | 4 | Chief Prod & Tech Officer | 25 Aug 2025, 15:16 |
| OPRX | OptimizeRx Corp | 15 Feb 2025 | 1 | -$9,203 | 4 | Chief Product Officer | 20 Feb 2025, 13:39 |
| OPRX | OptimizeRx Corp | 23 Dec 2024 | 2 | $0 | 4 | Chief Product Officer | 27 Dec 2024, 14:08 |
| OPRX | OptimizeRx Corp | 19 Dec 2024 | 3 | -$2,741 | 4 | Chief Product Officer | 20 Dec 2024, 19:47 |
| OPRX | OptimizeRx Corp | 03 Oct 2024 | 3 | -$7,642 | 4 | Chief Product Officer | 07 Oct 2024, 21:24 |
| OPRX | OptimizeRx Corp | 15 Feb 2024 | 1 | $0 | 4 | Chief Product Officer | 24 Apr 2024, 10:18 |
| OPRX | OptimizeRx Corp | 19 Dec 2023 | 2 | $0 | 4 | Chief Product Officer | 21 Feb 2024, 18:25 |
| OPRX | OptimizeRx Corp | 03 Oct 2023 | 3 | -$6,891 | 4 | Chief Product Officer | 06 Oct 2023, 14:47 |
| OPRX | OptimizeRx Corp | 03 Oct 2022 | 2 | $0 | 4 | Chief Product Officer | 05 Oct 2022, 13:14 |
| OPRX | OptimizeRx Corp | 01 Oct 2022 | 0 | $0 | 3 | Chief Product Officer | 03 Oct 2022, 14:57 |